NFSG
CORT icon

Newbridge Financial Services Group’s Corcept Therapeutics CORT Stock Holding History

Newbridge Financial Services Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.2K Hold
1,003
– – 0.01% 363
2026
Q1 		$40.4K Hold
1,003
– – 0.01% 476
2025
Q4 		$34.9K Buy
1,003
+48
+5% +$3.77K 0.01% 511
2025
Q3 		$79.4K Hold
955
– – 0.01% 425
2025
Q2 		$70.1K Hold
955
– – 0.01% 440
2025
Q1 		$109K Sell
955
-200
-17% -$12.2K 0.03% 254
2024
Q4 		$58.2K Buy
+1,155
New +$60.5K 0.01% 372

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Newbridge Financial Services Group's CORT Position: Q2 2026 in Review

Newbridge Financial Services Group held its Corcept Therapeutics (CORT) position steady in Q2 2026 at 1,003 shares worth $87.2K. The position accounts for 0.01% of the portfolio, ranked #363.

Newbridge Financial Services Group first reported a position in CORT in Q4 2024 and has held it in 7 quarters since. The position peaked at $109K in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Newbridge Financial Services Group held 1,003 shares of Corcept Therapeutics worth $87.2K as of Q2 2026.
  • Newbridge Financial Services Group left its Corcept Therapeutics share count unchanged in Q2 2026.
  • Corcept Therapeutics made up 0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #363 holding.
  • Newbridge Financial Services Group first reported a position in Corcept Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Newbridge Financial Services Group's Corcept Therapeutics position peaked at $109K in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.